ResearcherSun Yat-sen UniversityActive in the last 2 years
Yan Zeng
Matched on ORCID iD 0000-0002-0925-7879; OpenAlex author ID A5100374223. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2024: 1 paper · 2025: 2 papers
Papers 3
- TSPAN7 inhibits pancreatic cancer progression by suppressing DNA double-strand break repair and enhances sensitivity to immunochemotherapy. Co-author DOI 10.1016/j.bcp.2025.117199↗
- Single-cell transcriptome analysis identifies MIF as a novel tumor-associated neutrophil marker for pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41698-025-01085-3↗
- GDNF-induced phosphorylation of MUC21 promotes pancreatic cancer perineural invasion and metastasis by activating RAC2 GTPase. Co-author DOI 10.1038/s41388-024-03102-4↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yaning Li · 3 shared papers, 2024–2025 · strength 0.67
- Paper Single-cell transcriptome analysis identifies MIF as a novel tumor-associated neutrophil marker for pancreatic ductal a… DOI 10.1038/s41698-025-01085-3↗
- Paper TSPAN7 inhibits pancreatic cancer progression by suppressing DNA double-strand break repair and enhances sensitivity to… DOI 10.1016/j.bcp.2025.117199↗
- Paper GDNF-induced phosphorylation of MUC21 promotes pancreatic cancer perineural invasion and metastasis by activating RAC2 … DOI 10.1038/s41388-024-03102-4↗
- Linjuan Zeng · 3 shared papers, 2024–2025 · strength 0.67
- Paper Single-cell transcriptome analysis identifies MIF as a novel tumor-associated neutrophil marker for pancreatic ductal a… DOI 10.1038/s41698-025-01085-3↗
- Paper TSPAN7 inhibits pancreatic cancer progression by suppressing DNA double-strand break repair and enhances sensitivity to… DOI 10.1016/j.bcp.2025.117199↗
- Paper GDNF-induced phosphorylation of MUC21 promotes pancreatic cancer perineural invasion and metastasis by activating RAC2 … DOI 10.1038/s41388-024-03102-4↗
- Lisi Luo · 1 shared paper, 2025 · strength 0.23
- Hai Lin · 1 shared paper, 2025 · strength 0.23
- Yutong Chen · 1 shared paper, 2024 · strength 0.18
- Hai Lin · 1 shared paper, 2024 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.